Jamie Gibfried

Senior Director Bristol Myers Squibb

Jamie leads the US Cell Therapy Access strategy across all channels, including inline brands and indications, along with pipeline programs nearing US commercialization, for Bristol Myers Squibb, a leader in the development of novel CAR T therapies. Jamie have been on the access team at BMS for 17 years working in various leadership capacities across access strategy, patient support services, and field access.

Jamie Gibfried Speaker - 3rd Cell & Gene Therapy Pricing & Reimbursement Summit